Global Wearable Injectors and Connected Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Wearable Injectors and Connected Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 119

Published Date: 27 Apr 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Wearable Injectors and Connected Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Wearable Injectors and Connected Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Wearable Injectors and Connected Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Disposable segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Wearable Injectors and Connected Devices include Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, and Ypsomed, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Wearable Injectors and Connected Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Disposable
Reusable

Market segment by Application can be divided into
Hospitals
Clinics
Home Care Settings
Others

The key market players for global Wearable Injectors and Connected Devices market are listed below:
Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Enable Injections
Unilife Corporation
West Pharma
Eitan Medical
BD Medical
Noble International
Insulet
Amgen
Roche
CeQur
ScPharmaceuticals

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Wearable Injectors and Connected Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Wearable Injectors and Connected Devices, with price, sales, revenue and global market share of Wearable Injectors and Connected Devices from 2019 to 2022.
Chapter 3, the Wearable Injectors and Connected Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Wearable Injectors and Connected Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Wearable Injectors and Connected Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Wearable Injectors and Connected Devices.
Chapter 13, 14, and 15, to describe Wearable Injectors and Connected Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Wearable Injectors and Connected Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Wearable Injectors and Connected Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Disposable
1.2.3 Reusable
1.3 Market Analysis by Application
1.3.1 Overview: Global Wearable Injectors and Connected Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care Settings
1.3.5 Others
1.4 Global Wearable Injectors and Connected Devices Market Size & Forecast
1.4.1 Global Wearable Injectors and Connected Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Wearable Injectors and Connected Devices Sales in Volume (2017-2028)
1.4.3 Global Wearable Injectors and Connected Devices Price (2017-2028)
1.5 Global Wearable Injectors and Connected Devices Production Capacity Analysis
1.5.1 Global Wearable Injectors and Connected Devices Total Production Capacity (2017-2028)
1.5.2 Global Wearable Injectors and Connected Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Wearable Injectors and Connected Devices Market Drivers
1.6.2 Wearable Injectors and Connected Devices Market Restraints
1.6.3 Wearable Injectors and Connected Devices Trends Analysis

2 Manufacturers Profiles
2.1 Gerresheimer
2.1.1 Gerresheimer Details
2.1.2 Gerresheimer Major Business
2.1.3 Gerresheimer Wearable Injectors and Connected Devices Product and Services
2.1.4 Gerresheimer Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Owen Mumford
2.2.1 Owen Mumford Details
2.2.2 Owen Mumford Major Business
2.2.3 Owen Mumford Wearable Injectors and Connected Devices Product and Services
2.2.4 Owen Mumford Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sonceboz
2.3.1 Sonceboz Details
2.3.2 Sonceboz Major Business
2.3.3 Sonceboz Wearable Injectors and Connected Devices Product and Services
2.3.4 Sonceboz Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 United Therapeutics
2.4.1 United Therapeutics Details
2.4.2 United Therapeutics Major Business
2.4.3 United Therapeutics Wearable Injectors and Connected Devices Product and Services
2.4.4 United Therapeutics Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Ypsomed
2.5.1 Ypsomed Details
2.5.2 Ypsomed Major Business
2.5.3 Ypsomed Wearable Injectors and Connected Devices Product and Services
2.5.4 Ypsomed Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Elcam Medical
2.6.1 Elcam Medical Details
2.6.2 Elcam Medical Major Business
2.6.3 Elcam Medical Wearable Injectors and Connected Devices Product and Services
2.6.4 Elcam Medical Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Enable Injections
2.7.1 Enable Injections Details
2.7.2 Enable Injections Major Business
2.7.3 Enable Injections Wearable Injectors and Connected Devices Product and Services
2.7.4 Enable Injections Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Unilife Corporation
2.8.1 Unilife Corporation Details
2.8.2 Unilife Corporation Major Business
2.8.3 Unilife Corporation Wearable Injectors and Connected Devices Product and Services
2.8.4 Unilife Corporation Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 West Pharma
2.9.1 West Pharma Details
2.9.2 West Pharma Major Business
2.9.3 West Pharma Wearable Injectors and Connected Devices Product and Services
2.9.4 West Pharma Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Eitan Medical
2.10.1 Eitan Medical Details
2.10.2 Eitan Medical Major Business
2.10.3 Eitan Medical Wearable Injectors and Connected Devices Product and Services
2.10.4 Eitan Medical Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 BD Medical
2.11.1 BD Medical Details
2.11.2 BD Medical Major Business
2.11.3 BD Medical Wearable Injectors and Connected Devices Product and Services
2.11.4 BD Medical Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Noble International
2.12.1 Noble International Details
2.12.2 Noble International Major Business
2.12.3 Noble International Wearable Injectors and Connected Devices Product and Services
2.12.4 Noble International Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Insulet
2.13.1 Insulet Details
2.13.2 Insulet Major Business
2.13.3 Insulet Wearable Injectors and Connected Devices Product and Services
2.13.4 Insulet Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Amgen
2.14.1 Amgen Details
2.14.2 Amgen Major Business
2.14.3 Amgen Wearable Injectors and Connected Devices Product and Services
2.14.4 Amgen Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Wearable Injectors and Connected Devices Product and Services
2.15.4 Roche Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 CeQur
2.16.1 CeQur Details
2.16.2 CeQur Major Business
2.16.3 CeQur Wearable Injectors and Connected Devices Product and Services
2.16.4 CeQur Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 ScPharmaceuticals
2.17.1 ScPharmaceuticals Details
2.17.2 ScPharmaceuticals Major Business
2.17.3 ScPharmaceuticals Wearable Injectors and Connected Devices Product and Services
2.17.4 ScPharmaceuticals Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Wearable Injectors and Connected Devices Breakdown Data by Manufacturer
3.1 Global Wearable Injectors and Connected Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Wearable Injectors and Connected Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Wearable Injectors and Connected Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Wearable Injectors and Connected Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Wearable Injectors and Connected Devices Manufacturer Market Share in 2021
3.5 Global Wearable Injectors and Connected Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Wearable Injectors and Connected Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Wearable Injectors and Connected Devices Market Size by Region
4.1.1 Global Wearable Injectors and Connected Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Wearable Injectors and Connected Devices Revenue by Region (2017-2028)
4.2 North America Wearable Injectors and Connected Devices Revenue (2017-2028)
4.3 Europe Wearable Injectors and Connected Devices Revenue (2017-2028)
4.4 Asia-Pacific Wearable Injectors and Connected Devices Revenue (2017-2028)
4.5 South America Wearable Injectors and Connected Devices Revenue (2017-2028)
4.6 Middle East and Africa Wearable Injectors and Connected Devices Revenue (2017-2028)

5 Market Segment by Type
5.1 Global Wearable Injectors and Connected Devices Sales in Volume by Type (2017-2028)
5.2 Global Wearable Injectors and Connected Devices Revenue by Type (2017-2028)
5.3 Global Wearable Injectors and Connected Devices Price by Type (2017-2028)

6 Market Segment by Application
6.1 Global Wearable Injectors and Connected Devices Sales in Volume by Application (2017-2028)
6.2 Global Wearable Injectors and Connected Devices Revenue by Application (2017-2028)
6.3 Global Wearable Injectors and Connected Devices Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
7.1 North America Wearable Injectors and Connected Devices Sales by Type (2017-2028)
7.2 North America Wearable Injectors and Connected Devices Sales by Application (2017-2028)
7.3 North America Wearable Injectors and Connected Devices Market Size by Country
7.3.1 North America Wearable Injectors and Connected Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Wearable Injectors and Connected Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
8.1 Europe Wearable Injectors and Connected Devices Sales by Type (2017-2028)
8.2 Europe Wearable Injectors and Connected Devices Sales by Application (2017-2028)
8.3 Europe Wearable Injectors and Connected Devices Market Size by Country
8.3.1 Europe Wearable Injectors and Connected Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Wearable Injectors and Connected Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Wearable Injectors and Connected Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Wearable Injectors and Connected Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Wearable Injectors and Connected Devices Market Size by Region
9.3.1 Asia-Pacific Wearable Injectors and Connected Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Wearable Injectors and Connected Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
10.1 South America Wearable Injectors and Connected Devices Sales by Type (2017-2028)
10.2 South America Wearable Injectors and Connected Devices Sales by Application (2017-2028)
10.3 South America Wearable Injectors and Connected Devices Market Size by Country
10.3.1 South America Wearable Injectors and Connected Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Wearable Injectors and Connected Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Wearable Injectors and Connected Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Wearable Injectors and Connected Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Wearable Injectors and Connected Devices Market Size by Country
11.3.1 Middle East & Africa Wearable Injectors and Connected Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Wearable Injectors and Connected Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
12.1 Raw Material of Wearable Injectors and Connected Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Wearable Injectors and Connected Devices
12.3 Wearable Injectors and Connected Devices Production Process
12.4 Wearable Injectors and Connected Devices Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Wearable Injectors and Connected Devices Typical Distributors
13.3 Wearable Injectors and Connected Devices Typical Customers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Wearable Injectors and Connected Devices Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Wearable Injectors and Connected Devices Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Gerresheimer Basic Information, Manufacturing Base and Competitors
Table 4. Gerresheimer Major Business
Table 5. Gerresheimer Wearable Injectors and Connected Devices Product and Services
Table 6. Gerresheimer Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 8. Owen Mumford Major Business
Table 9. Owen Mumford Wearable Injectors and Connected Devices Product and Services
Table 10. Owen Mumford Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sonceboz Basic Information, Manufacturing Base and Competitors
Table 12. Sonceboz Major Business
Table 13. Sonceboz Wearable Injectors and Connected Devices Product and Services
Table 14. Sonceboz Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. United Therapeutics Basic Information, Manufacturing Base and Competitors
Table 16. United Therapeutics Major Business
Table 17. United Therapeutics Wearable Injectors and Connected Devices Product and Services
Table 18. United Therapeutics Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 20. Ypsomed Major Business
Table 21. Ypsomed Wearable Injectors and Connected Devices Product and Services
Table 22. Ypsomed Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Elcam Medical Basic Information, Manufacturing Base and Competitors
Table 24. Elcam Medical Major Business
Table 25. Elcam Medical Wearable Injectors and Connected Devices Product and Services
Table 26. Elcam Medical Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Enable Injections Basic Information, Manufacturing Base and Competitors
Table 28. Enable Injections Major Business
Table 29. Enable Injections Wearable Injectors and Connected Devices Product and Services
Table 30. Enable Injections Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Unilife Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Unilife Corporation Major Business
Table 33. Unilife Corporation Wearable Injectors and Connected Devices Product and Services
Table 34. Unilife Corporation Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. West Pharma Basic Information, Manufacturing Base and Competitors
Table 36. West Pharma Major Business
Table 37. West Pharma Wearable Injectors and Connected Devices Product and Services
Table 38. West Pharma Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Eitan Medical Basic Information, Manufacturing Base and Competitors
Table 40. Eitan Medical Major Business
Table 41. Eitan Medical Wearable Injectors and Connected Devices Product and Services
Table 42. Eitan Medical Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. BD Medical Basic Information, Manufacturing Base and Competitors
Table 44. BD Medical Major Business
Table 45. BD Medical Wearable Injectors and Connected Devices Product and Services
Table 46. BD Medical Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Noble International Basic Information, Manufacturing Base and Competitors
Table 48. Noble International Major Business
Table 49. Noble International Wearable Injectors and Connected Devices Product and Services
Table 50. Noble International Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Insulet Basic Information, Manufacturing Base and Competitors
Table 52. Insulet Major Business
Table 53. Insulet Wearable Injectors and Connected Devices Product and Services
Table 54. Insulet Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Amgen Basic Information, Manufacturing Base and Competitors
Table 56. Amgen Major Business
Table 57. Amgen Wearable Injectors and Connected Devices Product and Services
Table 58. Amgen Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Roche Basic Information, Manufacturing Base and Competitors
Table 60. Roche Major Business
Table 61. Roche Wearable Injectors and Connected Devices Product and Services
Table 62. Roche Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. CeQur Basic Information, Manufacturing Base and Competitors
Table 64. CeQur Major Business
Table 65. CeQur Wearable Injectors and Connected Devices Product and Services
Table 66. CeQur Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. ScPharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. ScPharmaceuticals Major Business
Table 69. ScPharmaceuticals Wearable Injectors and Connected Devices Product and Services
Table 70. ScPharmaceuticals Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Wearable Injectors and Connected Devices Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 72. Global Wearable Injectors and Connected Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Wearable Injectors and Connected Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Wearable Injectors and Connected Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 75. Head Office and Wearable Injectors and Connected Devices Production Site of Key Manufacturer
Table 76. Wearable Injectors and Connected Devices New Entrant and Capacity Expansion Plans
Table 77. Wearable Injectors and Connected Devices Mergers & Acquisitions in the Past Five Years
Table 78. Global Wearable Injectors and Connected Devices Sales by Region (2017-2022) & (K Units)
Table 79. Global Wearable Injectors and Connected Devices Sales by Region (2023-2028) & (K Units)
Table 80. Global Wearable Injectors and Connected Devices Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Wearable Injectors and Connected Devices Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 83. Global Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 84. Global Wearable Injectors and Connected Devices Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Wearable Injectors and Connected Devices Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Wearable Injectors and Connected Devices Price by Type (2017-2022) & (US$/Unit)
Table 87. Global Wearable Injectors and Connected Devices Price by Type (2023-2028) & (US$/Unit)
Table 88. Global Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 89. Global Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 90. Global Wearable Injectors and Connected Devices Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Wearable Injectors and Connected Devices Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Wearable Injectors and Connected Devices Price by Application (2017-2022) & (US$/Unit)
Table 93. Global Wearable Injectors and Connected Devices Price by Application (2023-2028) & (US$/Unit)
Table 94. North America Wearable Injectors and Connected Devices Sales by Country (2017-2022) & (K Units)
Table 95. North America Wearable Injectors and Connected Devices Sales by Country (2023-2028) & (K Units)
Table 96. North America Wearable Injectors and Connected Devices Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Wearable Injectors and Connected Devices Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 99. North America Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 100. North America Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 101. North America Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 102. Europe Wearable Injectors and Connected Devices Sales by Country (2017-2022) & (K Units)
Table 103. Europe Wearable Injectors and Connected Devices Sales by Country (2023-2028) & (K Units)
Table 104. Europe Wearable Injectors and Connected Devices Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Wearable Injectors and Connected Devices Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 107. Europe Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 108. Europe Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 109. Europe Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 110. Asia-Pacific Wearable Injectors and Connected Devices Sales by Region (2017-2022) & (K Units)
Table 111. Asia-Pacific Wearable Injectors and Connected Devices Sales by Region (2023-2028) & (K Units)
Table 112. Asia-Pacific Wearable Injectors and Connected Devices Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Wearable Injectors and Connected Devices Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 115. Asia-Pacific Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 116. Asia-Pacific Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 117. Asia-Pacific Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 118. South America Wearable Injectors and Connected Devices Sales by Country (2017-2022) & (K Units)
Table 119. South America Wearable Injectors and Connected Devices Sales by Country (2023-2028) & (K Units)
Table 120. South America Wearable Injectors and Connected Devices Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Wearable Injectors and Connected Devices Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 123. South America Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 124. South America Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 125. South America Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 126. Middle East & Africa Wearable Injectors and Connected Devices Sales by Region (2017-2022) & (K Units)
Table 127. Middle East & Africa Wearable Injectors and Connected Devices Sales by Region (2023-2028) & (K Units)
Table 128. Middle East & Africa Wearable Injectors and Connected Devices Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Wearable Injectors and Connected Devices Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 131. Middle East & Africa Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 132. Middle East & Africa Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 133. Middle East & Africa Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 134. Wearable Injectors and Connected Devices Raw Material
Table 135. Key Manufacturers of Wearable Injectors and Connected Devices Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Wearable Injectors and Connected Devices Typical Distributors
Table 139. Wearable Injectors and Connected Devices Typical Customers
List of Figures
Figure 1. Wearable Injectors and Connected Devices Picture
Figure 2. Global Wearable Injectors and Connected Devices Revenue Market Share by Type in 2021
Figure 3. Disposable
Figure 4. Reusable
Figure 5. Global Wearable Injectors and Connected Devices Revenue Market Share by Application in 2021
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Home Care Settings
Figure 9. Others
Figure 10. Global Wearable Injectors and Connected Devices Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Wearable Injectors and Connected Devices Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Wearable Injectors and Connected Devices Sales (2017-2028) & (K Units)
Figure 13. Global Wearable Injectors and Connected Devices Price (2017-2028) & (US$/Unit)
Figure 14. Global Wearable Injectors and Connected Devices Production Capacity (2017-2028) & (K Units)
Figure 15. Global Wearable Injectors and Connected Devices Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Wearable Injectors and Connected Devices Market Drivers
Figure 17. Wearable Injectors and Connected Devices Market Restraints
Figure 18. Wearable Injectors and Connected Devices Market Trends
Figure 19. Global Wearable Injectors and Connected Devices Sales Market Share by Manufacturer in 2021
Figure 20. Global Wearable Injectors and Connected Devices Revenue Market Share by Manufacturer in 2021
Figure 21. Wearable Injectors and Connected Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Wearable Injectors and Connected Devices Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Wearable Injectors and Connected Devices Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2017-2028)
Figure 25. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2017-2028)
Figure 26. North America Wearable Injectors and Connected Devices Revenue (2017-2028) & (USD Million)
Figure 27. Europe Wearable Injectors and Connected Devices Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Wearable Injectors and Connected Devices Revenue (2017-2028) & (USD Million)
Figure 29. South America Wearable Injectors and Connected Devices Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Wearable Injectors and Connected Devices Revenue (2017-2028) & (USD Million)
Figure 31. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2028)
Figure 32. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2017-2028)
Figure 33. Global Wearable Injectors and Connected Devices Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 35. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2017-2028)
Figure 36. Global Wearable Injectors and Connected Devices Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2028)
Figure 38. North America Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 39. North America Wearable Injectors and Connected Devices Sales Market Share by Country (2017-2028)
Figure 40. North America Wearable Injectors and Connected Devices Revenue Market Share by Country (2017-2028)
Figure 41. United States Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2028)
Figure 45. Europe Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 46. Europe Wearable Injectors and Connected Devices Sales Market Share by Country (2017-2028)
Figure 47. Europe Wearable Injectors and Connected Devices Revenue Market Share by Country (2017-2028)
Figure 48. Germany Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Wearable Injectors and Connected Devices Revenue Market Share by Region (2017-2028)
Figure 57. China Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2028)
Figure 64. South America Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 65. South America Wearable Injectors and Connected Devices Sales Market Share by Country (2017-2028)
Figure 66. South America Wearable Injectors and Connected Devices Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Wearable Injectors and Connected Devices Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Wearable Injectors and Connected Devices Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Wearable Injectors and Connected Devices in 2021
Figure 78. Manufacturing Process Analysis of Wearable Injectors and Connected Devices
Figure 79. Wearable Injectors and Connected Devices Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Enable Injections
Unilife Corporation
West Pharma
Eitan Medical
BD Medical
Noble International
Insulet
Amgen
Roche
CeQur
ScPharmaceuticals
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Wearable Injectors and Connected Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Wearable Injectors and Connected Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 119

Published Date: 27 Apr 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Wearable Injectors and Connected Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Wearable Injectors and Connected Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Wearable Injectors and Connected Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Disposable segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Wearable Injectors and Connected Devices include Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, and Ypsomed, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Wearable Injectors and Connected Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Disposable
Reusable

Market segment by Application can be divided into
Hospitals
Clinics
Home Care Settings
Others

The key market players for global Wearable Injectors and Connected Devices market are listed below:
Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Enable Injections
Unilife Corporation
West Pharma
Eitan Medical
BD Medical
Noble International
Insulet
Amgen
Roche
CeQur
ScPharmaceuticals

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Wearable Injectors and Connected Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Wearable Injectors and Connected Devices, with price, sales, revenue and global market share of Wearable Injectors and Connected Devices from 2019 to 2022.
Chapter 3, the Wearable Injectors and Connected Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Wearable Injectors and Connected Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Wearable Injectors and Connected Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Wearable Injectors and Connected Devices.
Chapter 13, 14, and 15, to describe Wearable Injectors and Connected Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Wearable Injectors and Connected Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Wearable Injectors and Connected Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Disposable
1.2.3 Reusable
1.3 Market Analysis by Application
1.3.1 Overview: Global Wearable Injectors and Connected Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care Settings
1.3.5 Others
1.4 Global Wearable Injectors and Connected Devices Market Size & Forecast
1.4.1 Global Wearable Injectors and Connected Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Wearable Injectors and Connected Devices Sales in Volume (2017-2028)
1.4.3 Global Wearable Injectors and Connected Devices Price (2017-2028)
1.5 Global Wearable Injectors and Connected Devices Production Capacity Analysis
1.5.1 Global Wearable Injectors and Connected Devices Total Production Capacity (2017-2028)
1.5.2 Global Wearable Injectors and Connected Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Wearable Injectors and Connected Devices Market Drivers
1.6.2 Wearable Injectors and Connected Devices Market Restraints
1.6.3 Wearable Injectors and Connected Devices Trends Analysis

2 Manufacturers Profiles
2.1 Gerresheimer
2.1.1 Gerresheimer Details
2.1.2 Gerresheimer Major Business
2.1.3 Gerresheimer Wearable Injectors and Connected Devices Product and Services
2.1.4 Gerresheimer Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Owen Mumford
2.2.1 Owen Mumford Details
2.2.2 Owen Mumford Major Business
2.2.3 Owen Mumford Wearable Injectors and Connected Devices Product and Services
2.2.4 Owen Mumford Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sonceboz
2.3.1 Sonceboz Details
2.3.2 Sonceboz Major Business
2.3.3 Sonceboz Wearable Injectors and Connected Devices Product and Services
2.3.4 Sonceboz Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 United Therapeutics
2.4.1 United Therapeutics Details
2.4.2 United Therapeutics Major Business
2.4.3 United Therapeutics Wearable Injectors and Connected Devices Product and Services
2.4.4 United Therapeutics Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Ypsomed
2.5.1 Ypsomed Details
2.5.2 Ypsomed Major Business
2.5.3 Ypsomed Wearable Injectors and Connected Devices Product and Services
2.5.4 Ypsomed Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Elcam Medical
2.6.1 Elcam Medical Details
2.6.2 Elcam Medical Major Business
2.6.3 Elcam Medical Wearable Injectors and Connected Devices Product and Services
2.6.4 Elcam Medical Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Enable Injections
2.7.1 Enable Injections Details
2.7.2 Enable Injections Major Business
2.7.3 Enable Injections Wearable Injectors and Connected Devices Product and Services
2.7.4 Enable Injections Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Unilife Corporation
2.8.1 Unilife Corporation Details
2.8.2 Unilife Corporation Major Business
2.8.3 Unilife Corporation Wearable Injectors and Connected Devices Product and Services
2.8.4 Unilife Corporation Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 West Pharma
2.9.1 West Pharma Details
2.9.2 West Pharma Major Business
2.9.3 West Pharma Wearable Injectors and Connected Devices Product and Services
2.9.4 West Pharma Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Eitan Medical
2.10.1 Eitan Medical Details
2.10.2 Eitan Medical Major Business
2.10.3 Eitan Medical Wearable Injectors and Connected Devices Product and Services
2.10.4 Eitan Medical Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 BD Medical
2.11.1 BD Medical Details
2.11.2 BD Medical Major Business
2.11.3 BD Medical Wearable Injectors and Connected Devices Product and Services
2.11.4 BD Medical Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Noble International
2.12.1 Noble International Details
2.12.2 Noble International Major Business
2.12.3 Noble International Wearable Injectors and Connected Devices Product and Services
2.12.4 Noble International Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Insulet
2.13.1 Insulet Details
2.13.2 Insulet Major Business
2.13.3 Insulet Wearable Injectors and Connected Devices Product and Services
2.13.4 Insulet Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Amgen
2.14.1 Amgen Details
2.14.2 Amgen Major Business
2.14.3 Amgen Wearable Injectors and Connected Devices Product and Services
2.14.4 Amgen Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Wearable Injectors and Connected Devices Product and Services
2.15.4 Roche Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 CeQur
2.16.1 CeQur Details
2.16.2 CeQur Major Business
2.16.3 CeQur Wearable Injectors and Connected Devices Product and Services
2.16.4 CeQur Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 ScPharmaceuticals
2.17.1 ScPharmaceuticals Details
2.17.2 ScPharmaceuticals Major Business
2.17.3 ScPharmaceuticals Wearable Injectors and Connected Devices Product and Services
2.17.4 ScPharmaceuticals Wearable Injectors and Connected Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Wearable Injectors and Connected Devices Breakdown Data by Manufacturer
3.1 Global Wearable Injectors and Connected Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Wearable Injectors and Connected Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Wearable Injectors and Connected Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Wearable Injectors and Connected Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Wearable Injectors and Connected Devices Manufacturer Market Share in 2021
3.5 Global Wearable Injectors and Connected Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Wearable Injectors and Connected Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Wearable Injectors and Connected Devices Market Size by Region
4.1.1 Global Wearable Injectors and Connected Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Wearable Injectors and Connected Devices Revenue by Region (2017-2028)
4.2 North America Wearable Injectors and Connected Devices Revenue (2017-2028)
4.3 Europe Wearable Injectors and Connected Devices Revenue (2017-2028)
4.4 Asia-Pacific Wearable Injectors and Connected Devices Revenue (2017-2028)
4.5 South America Wearable Injectors and Connected Devices Revenue (2017-2028)
4.6 Middle East and Africa Wearable Injectors and Connected Devices Revenue (2017-2028)

5 Market Segment by Type
5.1 Global Wearable Injectors and Connected Devices Sales in Volume by Type (2017-2028)
5.2 Global Wearable Injectors and Connected Devices Revenue by Type (2017-2028)
5.3 Global Wearable Injectors and Connected Devices Price by Type (2017-2028)

6 Market Segment by Application
6.1 Global Wearable Injectors and Connected Devices Sales in Volume by Application (2017-2028)
6.2 Global Wearable Injectors and Connected Devices Revenue by Application (2017-2028)
6.3 Global Wearable Injectors and Connected Devices Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
7.1 North America Wearable Injectors and Connected Devices Sales by Type (2017-2028)
7.2 North America Wearable Injectors and Connected Devices Sales by Application (2017-2028)
7.3 North America Wearable Injectors and Connected Devices Market Size by Country
7.3.1 North America Wearable Injectors and Connected Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Wearable Injectors and Connected Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
8.1 Europe Wearable Injectors and Connected Devices Sales by Type (2017-2028)
8.2 Europe Wearable Injectors and Connected Devices Sales by Application (2017-2028)
8.3 Europe Wearable Injectors and Connected Devices Market Size by Country
8.3.1 Europe Wearable Injectors and Connected Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Wearable Injectors and Connected Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Wearable Injectors and Connected Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Wearable Injectors and Connected Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Wearable Injectors and Connected Devices Market Size by Region
9.3.1 Asia-Pacific Wearable Injectors and Connected Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Wearable Injectors and Connected Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
10.1 South America Wearable Injectors and Connected Devices Sales by Type (2017-2028)
10.2 South America Wearable Injectors and Connected Devices Sales by Application (2017-2028)
10.3 South America Wearable Injectors and Connected Devices Market Size by Country
10.3.1 South America Wearable Injectors and Connected Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Wearable Injectors and Connected Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Wearable Injectors and Connected Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Wearable Injectors and Connected Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Wearable Injectors and Connected Devices Market Size by Country
11.3.1 Middle East & Africa Wearable Injectors and Connected Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Wearable Injectors and Connected Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
12.1 Raw Material of Wearable Injectors and Connected Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Wearable Injectors and Connected Devices
12.3 Wearable Injectors and Connected Devices Production Process
12.4 Wearable Injectors and Connected Devices Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Wearable Injectors and Connected Devices Typical Distributors
13.3 Wearable Injectors and Connected Devices Typical Customers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Wearable Injectors and Connected Devices Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Wearable Injectors and Connected Devices Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Gerresheimer Basic Information, Manufacturing Base and Competitors
Table 4. Gerresheimer Major Business
Table 5. Gerresheimer Wearable Injectors and Connected Devices Product and Services
Table 6. Gerresheimer Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 8. Owen Mumford Major Business
Table 9. Owen Mumford Wearable Injectors and Connected Devices Product and Services
Table 10. Owen Mumford Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sonceboz Basic Information, Manufacturing Base and Competitors
Table 12. Sonceboz Major Business
Table 13. Sonceboz Wearable Injectors and Connected Devices Product and Services
Table 14. Sonceboz Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. United Therapeutics Basic Information, Manufacturing Base and Competitors
Table 16. United Therapeutics Major Business
Table 17. United Therapeutics Wearable Injectors and Connected Devices Product and Services
Table 18. United Therapeutics Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 20. Ypsomed Major Business
Table 21. Ypsomed Wearable Injectors and Connected Devices Product and Services
Table 22. Ypsomed Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Elcam Medical Basic Information, Manufacturing Base and Competitors
Table 24. Elcam Medical Major Business
Table 25. Elcam Medical Wearable Injectors and Connected Devices Product and Services
Table 26. Elcam Medical Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Enable Injections Basic Information, Manufacturing Base and Competitors
Table 28. Enable Injections Major Business
Table 29. Enable Injections Wearable Injectors and Connected Devices Product and Services
Table 30. Enable Injections Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Unilife Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Unilife Corporation Major Business
Table 33. Unilife Corporation Wearable Injectors and Connected Devices Product and Services
Table 34. Unilife Corporation Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. West Pharma Basic Information, Manufacturing Base and Competitors
Table 36. West Pharma Major Business
Table 37. West Pharma Wearable Injectors and Connected Devices Product and Services
Table 38. West Pharma Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Eitan Medical Basic Information, Manufacturing Base and Competitors
Table 40. Eitan Medical Major Business
Table 41. Eitan Medical Wearable Injectors and Connected Devices Product and Services
Table 42. Eitan Medical Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. BD Medical Basic Information, Manufacturing Base and Competitors
Table 44. BD Medical Major Business
Table 45. BD Medical Wearable Injectors and Connected Devices Product and Services
Table 46. BD Medical Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Noble International Basic Information, Manufacturing Base and Competitors
Table 48. Noble International Major Business
Table 49. Noble International Wearable Injectors and Connected Devices Product and Services
Table 50. Noble International Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Insulet Basic Information, Manufacturing Base and Competitors
Table 52. Insulet Major Business
Table 53. Insulet Wearable Injectors and Connected Devices Product and Services
Table 54. Insulet Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Amgen Basic Information, Manufacturing Base and Competitors
Table 56. Amgen Major Business
Table 57. Amgen Wearable Injectors and Connected Devices Product and Services
Table 58. Amgen Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Roche Basic Information, Manufacturing Base and Competitors
Table 60. Roche Major Business
Table 61. Roche Wearable Injectors and Connected Devices Product and Services
Table 62. Roche Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. CeQur Basic Information, Manufacturing Base and Competitors
Table 64. CeQur Major Business
Table 65. CeQur Wearable Injectors and Connected Devices Product and Services
Table 66. CeQur Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. ScPharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. ScPharmaceuticals Major Business
Table 69. ScPharmaceuticals Wearable Injectors and Connected Devices Product and Services
Table 70. ScPharmaceuticals Wearable Injectors and Connected Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Wearable Injectors and Connected Devices Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 72. Global Wearable Injectors and Connected Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Wearable Injectors and Connected Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Wearable Injectors and Connected Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 75. Head Office and Wearable Injectors and Connected Devices Production Site of Key Manufacturer
Table 76. Wearable Injectors and Connected Devices New Entrant and Capacity Expansion Plans
Table 77. Wearable Injectors and Connected Devices Mergers & Acquisitions in the Past Five Years
Table 78. Global Wearable Injectors and Connected Devices Sales by Region (2017-2022) & (K Units)
Table 79. Global Wearable Injectors and Connected Devices Sales by Region (2023-2028) & (K Units)
Table 80. Global Wearable Injectors and Connected Devices Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Wearable Injectors and Connected Devices Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 83. Global Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 84. Global Wearable Injectors and Connected Devices Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Wearable Injectors and Connected Devices Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Wearable Injectors and Connected Devices Price by Type (2017-2022) & (US$/Unit)
Table 87. Global Wearable Injectors and Connected Devices Price by Type (2023-2028) & (US$/Unit)
Table 88. Global Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 89. Global Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 90. Global Wearable Injectors and Connected Devices Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Wearable Injectors and Connected Devices Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Wearable Injectors and Connected Devices Price by Application (2017-2022) & (US$/Unit)
Table 93. Global Wearable Injectors and Connected Devices Price by Application (2023-2028) & (US$/Unit)
Table 94. North America Wearable Injectors and Connected Devices Sales by Country (2017-2022) & (K Units)
Table 95. North America Wearable Injectors and Connected Devices Sales by Country (2023-2028) & (K Units)
Table 96. North America Wearable Injectors and Connected Devices Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Wearable Injectors and Connected Devices Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 99. North America Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 100. North America Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 101. North America Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 102. Europe Wearable Injectors and Connected Devices Sales by Country (2017-2022) & (K Units)
Table 103. Europe Wearable Injectors and Connected Devices Sales by Country (2023-2028) & (K Units)
Table 104. Europe Wearable Injectors and Connected Devices Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Wearable Injectors and Connected Devices Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 107. Europe Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 108. Europe Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 109. Europe Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 110. Asia-Pacific Wearable Injectors and Connected Devices Sales by Region (2017-2022) & (K Units)
Table 111. Asia-Pacific Wearable Injectors and Connected Devices Sales by Region (2023-2028) & (K Units)
Table 112. Asia-Pacific Wearable Injectors and Connected Devices Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Wearable Injectors and Connected Devices Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 115. Asia-Pacific Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 116. Asia-Pacific Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 117. Asia-Pacific Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 118. South America Wearable Injectors and Connected Devices Sales by Country (2017-2022) & (K Units)
Table 119. South America Wearable Injectors and Connected Devices Sales by Country (2023-2028) & (K Units)
Table 120. South America Wearable Injectors and Connected Devices Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Wearable Injectors and Connected Devices Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 123. South America Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 124. South America Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 125. South America Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 126. Middle East & Africa Wearable Injectors and Connected Devices Sales by Region (2017-2022) & (K Units)
Table 127. Middle East & Africa Wearable Injectors and Connected Devices Sales by Region (2023-2028) & (K Units)
Table 128. Middle East & Africa Wearable Injectors and Connected Devices Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Wearable Injectors and Connected Devices Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Wearable Injectors and Connected Devices Sales by Type (2017-2022) & (K Units)
Table 131. Middle East & Africa Wearable Injectors and Connected Devices Sales by Type (2023-2028) & (K Units)
Table 132. Middle East & Africa Wearable Injectors and Connected Devices Sales by Application (2017-2022) & (K Units)
Table 133. Middle East & Africa Wearable Injectors and Connected Devices Sales by Application (2023-2028) & (K Units)
Table 134. Wearable Injectors and Connected Devices Raw Material
Table 135. Key Manufacturers of Wearable Injectors and Connected Devices Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Wearable Injectors and Connected Devices Typical Distributors
Table 139. Wearable Injectors and Connected Devices Typical Customers
List of Figures
Figure 1. Wearable Injectors and Connected Devices Picture
Figure 2. Global Wearable Injectors and Connected Devices Revenue Market Share by Type in 2021
Figure 3. Disposable
Figure 4. Reusable
Figure 5. Global Wearable Injectors and Connected Devices Revenue Market Share by Application in 2021
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Home Care Settings
Figure 9. Others
Figure 10. Global Wearable Injectors and Connected Devices Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Wearable Injectors and Connected Devices Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Wearable Injectors and Connected Devices Sales (2017-2028) & (K Units)
Figure 13. Global Wearable Injectors and Connected Devices Price (2017-2028) & (US$/Unit)
Figure 14. Global Wearable Injectors and Connected Devices Production Capacity (2017-2028) & (K Units)
Figure 15. Global Wearable Injectors and Connected Devices Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Wearable Injectors and Connected Devices Market Drivers
Figure 17. Wearable Injectors and Connected Devices Market Restraints
Figure 18. Wearable Injectors and Connected Devices Market Trends
Figure 19. Global Wearable Injectors and Connected Devices Sales Market Share by Manufacturer in 2021
Figure 20. Global Wearable Injectors and Connected Devices Revenue Market Share by Manufacturer in 2021
Figure 21. Wearable Injectors and Connected Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Wearable Injectors and Connected Devices Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Wearable Injectors and Connected Devices Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2017-2028)
Figure 25. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2017-2028)
Figure 26. North America Wearable Injectors and Connected Devices Revenue (2017-2028) & (USD Million)
Figure 27. Europe Wearable Injectors and Connected Devices Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Wearable Injectors and Connected Devices Revenue (2017-2028) & (USD Million)
Figure 29. South America Wearable Injectors and Connected Devices Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Wearable Injectors and Connected Devices Revenue (2017-2028) & (USD Million)
Figure 31. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2028)
Figure 32. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2017-2028)
Figure 33. Global Wearable Injectors and Connected Devices Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 35. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2017-2028)
Figure 36. Global Wearable Injectors and Connected Devices Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2028)
Figure 38. North America Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 39. North America Wearable Injectors and Connected Devices Sales Market Share by Country (2017-2028)
Figure 40. North America Wearable Injectors and Connected Devices Revenue Market Share by Country (2017-2028)
Figure 41. United States Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2028)
Figure 45. Europe Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 46. Europe Wearable Injectors and Connected Devices Sales Market Share by Country (2017-2028)
Figure 47. Europe Wearable Injectors and Connected Devices Revenue Market Share by Country (2017-2028)
Figure 48. Germany Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Wearable Injectors and Connected Devices Revenue Market Share by Region (2017-2028)
Figure 57. China Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2028)
Figure 64. South America Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 65. South America Wearable Injectors and Connected Devices Sales Market Share by Country (2017-2028)
Figure 66. South America Wearable Injectors and Connected Devices Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Wearable Injectors and Connected Devices Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Wearable Injectors and Connected Devices Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Wearable Injectors and Connected Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Wearable Injectors and Connected Devices in 2021
Figure 78. Manufacturing Process Analysis of Wearable Injectors and Connected Devices
Figure 79. Wearable Injectors and Connected Devices Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Enable Injections
Unilife Corporation
West Pharma
Eitan Medical
BD Medical
Noble International
Insulet
Amgen
Roche
CeQur
ScPharmaceuticals
jiaGou

Add To Cart

gouMai

Buy Now